What Does Full FDA Approval of Moderna COVID Vaccine Mean? Asks Association of American Physicians and Surgeons (AAPS)
February 02, 2022 10:16 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Feb. 02, 2022 (GLOBE NEWSWIRE) -- The FDA has granted full approval to Moderna’s messenger RNA (mRNA) COVID19 shot, Spikevax™, for persons age 18 and older. There are now two approved...
4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
January 10, 2022 13:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration will combine...
4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
January 10, 2022 13:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration will combine...
Scientists & Academics, led by PrEP4All and Right to Health Action, demand global vaccine program at homes of Biden Chief of Staff and Moderna CEO
September 29, 2021 17:30 ET
|
PrEP4All
“Biden’s failed COVID summit was our last straw,” say scientists who held dual press conferences at the homes of White House Chief of Staff Ron Klain and Moderna CEO Stephane Bancel. Speakers at both...
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
August 11, 2021 08:35 ET
|
Dyadic International, Inc.
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and certain other countries to utilize Dyadic’s C1 technology for the...
Global WholeHealth Partners Corp (GWHP-OTC) Acquires Rights to Distribute & Sell a 3rd COVID-19 Vaccine - Moderna
June 29, 2021 07:00 ET
|
Global WholeHealth Partners Corp.
Moderna Generated $1.94 Billion in Revenue During the First Quarter, with $1.73 Billion Coming from Its COVID-19 Shot Company Now Has the Rights to Distribute & Sell Three of the Most Popular...
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
March 30, 2021 07:29 ET
|
Odyssey Group International
Irvine, CA, March 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing...
Pregnant Patients Should Weigh Risk of COVID Jab, States Association of American Physicians and Surgeons (AAPS)
March 04, 2021 13:39 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 04, 2021 (GLOBE NEWSWIRE) -- The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) have recommended that COVID-19...
Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments
January 06, 2021 13:14 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and...
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
December 29, 2020 17:20 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...